Loading
CP
Cerulean Pharma Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 12 Feb 2016.
Cerulean Pharma Inc.: what insiders have been doing
This page follows insider dealings at Cerulean Pharma Inc. as filed with SEC (Form 4). Nothing new has been filed by managers of Cerulean Pharma Inc. in twelve months, the latest record being from 12 February 2016.
Elsewhere in the same market, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
29
Thresholds
n/a
Buy Volume
n/a
28 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
Income statement
RevenueUS$891.8k
Net income-US$11.6M-1300.7% margin
Last declaration on 12 February 2016
Declarations29 total
4,500 sharesCommon StockSEC:0001209191-16-098014:0
Canonical exit: 10 May 2016 (T+90)
4,350 sharesCommon StockSEC:0001209191-16-098014:1
Canonical exit: 11 May 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-097270:0
Canonical exit: 8 May 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-097270:1
Canonical exit: 9 May 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-096365:1
Canonical exit: 5 May 2016 (T+90)
4,063 sharesCommon StockSEC:0001209191-16-096365:0
Canonical exit: 4 May 2016 (T+90)
4,395 sharesCommon StockSEC:0001209191-16-095726:0
Canonical exit: 2 May 2016 (T+90)
4,018 sharesCommon StockSEC:0001209191-16-095726:1
Canonical exit: 3 May 2016 (T+90)
1,200 sharesCommon StockSEC:0001209191-16-094706:0
Canonical exit: 28 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-094706:1
Canonical exit: 1 May 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-094149:0
Canonical exit: 26 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-094149:1
Canonical exit: 27 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-093783:0
Canonical exit: 24 Apr 2016 (T+90)
4,300 sharesCommon StockSEC:0001209191-16-093783:1
Canonical exit: 25 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-093420:0
Canonical exit: 20 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-093420:1
Canonical exit: 21 Apr 2016 (T+90)
4,400 sharesCommon StockSEC:0001209191-16-092885:0
Canonical exit: 18 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-092885:1
Canonical exit: 19 Apr 2016 (T+90)
4,400 sharesCommon StockSEC:0001209191-16-092049:0
Canonical exit: 13 Apr 2016 (T+90)
4,172 sharesCommon StockSEC:0001209191-16-092049:1
Canonical exit: 14 Apr 2016 (T+90)
4,300 sharesCommon StockSEC:0001209191-16-091409:0
Canonical exit: 11 Apr 2016 (T+90)
4,384 sharesCommon StockSEC:0001209191-16-091409:1
Canonical exit: 12 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-090953:0
Canonical exit: 7 Apr 2016 (T+90)
4,355 sharesCommon StockSEC:0001209191-16-090953:1
Canonical exit: 10 Apr 2016 (T+90)
4,500 sharesCommon StockSEC:0001209191-16-090585:0
Canonical exit: 5 Apr 2016 (T+90)
25 of 29 declarations
About Cerulean Pharma Inc.
Cerulean Pharma Inc. is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on NASDAQ under the ticker CRLN.
